Replies to post #170520 on Avid Bioservices Inc (CDMO)

[md1225]

Nice post CP! Frontline 22 months mos for bavi 3mg arm, 15 months mos for 2nd line 3mg arm. All imo of course :)

Little bird right CP.

[EYEBUYSTOX]

Something to keep in mind about the CSM complaint.

CP, I think you need to take a deep breath and realize just how hypocritical you're being in drawing every conclusion you have been from PEREGRINE's amended complaint when for the last 18 months you've been discrediting the same document from the plaintiff in the Class Action.

In summary, just because a plaintiff says the word fraud and secret motives, doesn't prove anything until a judge rules on it!

If we're using the plaintiff's wording in this complaint as fact simply because PPHM is the plaintiff then we must also assume everything the plaintiff has said in their amended class action complaint is true until a judge rules otherwise. And that is nonsense.

There are many reasons that this lawsuit will never go to trial and/or through discovery IMO. Many. Nobody wants that. Not CSM, Not Peregrine...not whoever was behind the labeling errors.

The lack of detailed PPHM information and timeline on page 7 (in an otherwise very detailed document) about finding the discrepancies while "preparing for and end of phase 2 meeting" is why PPHM doesn't want this to move on IMO.

The multiple infractions and FDA violations and possible incentive for creating them are an obvious reason CSM and/or some other entity working with them doesn't want this to move on IMO.

But please stop using a plaintiff's complaint in one lawsuit as scripture when you've just spent the last year discrediting another one as frivolous. It's just not fair debate.

Granted, the judge has already dismissed the class action complaint twice making it less credible; however, we haven't even read CSM's response to this complaint which probably has much "juicier" PPHM gossip within it IMO. My gut says we never will get the chance.

Lets at least wait for that before going overboard on the sabotage theory again, eh? It's equivalent to someone writing 3 long posts about PPHM committing securities fraud the day after the first class action complaint was filed.

[biopharm]

The board has been speculating in the past about the possible involvement of Jeanette Bleecker and/or
Angela Thompson.

Another red alert, but first, the lawsuit vs CSM in Fargo, ND will all hopefully come to a closure soon, and I its possible to imagine that the dose switching work at CSM was not contained to only one female, but certainly possible.

Anyhow, what are the odds... that all this time I speak about the links that show Peregrine is collaborating with Ambit Biosciences, and now we have a direct route leading right back to Angela Thompson Geiger-ex CSM employee and worked under Jeanette Bleecker.

RECEPTOS

Faheem Hasnain
President and CEO

Mr. Hasnain has served as our President, Chief Executive Officer and one of our directors since November 2010. Prior to joining us, Mr. Hasnain was the President and Chief Executive Officer and a director of Facet Biotech Corporation, a biology driven antibody company with a focus in multiple sclerosis and oncology. He held that position from December 2008 until the company's acquisition by Abbott Laboratories in April 2010. Previously, Mr. Hasnain was President, Chief Executive Officer and a director of PDL BioPharma, Inc. from October 2008 until Facet Biotech was spun off from PDL BioPharma in December 2008. From October 2004 to September 2008, Mr. Hasnain served at Biogen Idec Inc., a biotechnology company specializing in neurological disorders, autoimmune disorders and cancer, most recently as Executive Vice President in charge of the oncology/rheumatology strategic business unit. Prior to Biogen Idec, Mr. Hasnain held roles with Bristol Myers Squibb, where he was President of the Oncology Therapeutics Network, and for 14 years at GlaxoSmithKline and its predecessor organizations. Mr. Hasnain was appointed Chairman of the Board of Ambit Biosciences Corporation in November 2010 and serves on the board of directors of Aragon Pharmaceuticals. He has been Chairman of the Board of Sente, Inc. since 2008 and served as a member of the board of directors of Tercica, Inc. Mr. Hasnain received a B.H.K. and B.Ed. from the University of Windsor Ontario in Canada.

http://www.receptos.com/board-of-directors-at-receptos.php

http://www.ambitbio.com/Board_of_Directors

and we know there has always been multiple, direct ties to BMS to Ambit

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=103127149&txt2find=ambit

---------------------------------------------------------

..... and how may one ask is Angela Thompson involved? BMS ties ? C'mon, everyone must agree that the odds of this are slim to none and my goal, as always.... is making sure another Fargo does not come close, ever again. So when I see an ex-CSM employee with ties to a collaborator of Peregrine ( based on employee linkedin profiles), then Peregrine should be aware.... so here you go Tustin. Since its only Sept 5, she may still be in orientation....

Clinical Supply Chain Specialist
Receptos, Inc.
September 2014 – Present (1 month)

Project Manager, Global Clinical Supplies
PPD
June 2013 – April 2014 (11 months)Morrisville, NC (RTP)

Operations Project Manager
Clinical Supplies Management
August 2011 – March 2013 (1 year 8 months)

Newly Married and another job as a gift